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Chiral molecule (R)-3-quinuclidinol, a valuable compound for the production of various pharmaceuticals, is
efficiently synthesized from 3-quinuclidinone by using NADPH-dependent 3-quinuclidinone reductase (RrQR) from
Rhodotorula rubra. Here, we report the crystal structure of RrQR and the structure-based mutational analysis. The
enzyme forms a tetramer, in which the core of each protomer exhibits the α/β Rossmann fold and contains one
molecule of NADPH, whereas the characteristic substructures of a small lobe and a variable loop are localized around
the substrate-binding site. Modeling and mutation analyses of the catalytic site indicated that the hydrophobicity of
two residues, I167 and F212, determines the substrate-binding orientation as well as the substrate-binding affinity. Our
results revealed that the characteristic substrate-binding pocket composed of hydrophobic amino acid residues ensures
substrate docking for the stereospecific reaction of RrQR in spite of its loose interaction with the substrate.
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(R)-3-quinuclidinolIntroduction
The chirality of chemical compounds is an important
property for their availability as building blocks for phar-
maceuticals and chemicals, including chemical catalysts,
liquid crystals, flavors, agrochemicals, and medicines. As
is often the case, only one optical isomer primarily or
completely exhibits the intended activity. Therefore, it is
necessary to develop methods to produce optically pure
compounds for use in the industrial production of chiral
compounds. Biotransformations using whole cells and
enzyme-catalyzed reactions have been attempted for the
production of various chiral compounds. The enzymatic
asymmetric reduction of prochiral carbonyl compounds
is a promising method for the production of chiral alco-
hols, because enzymes have certain advantages for use
in chemical reactions under mild conditions and with
chemo-, regio-, and stereo-selectivity (Hummel 1997;
Kataoka et al. 2003; Goldberg et al. 2007). Structural
information about useful enzymes would enable the* Correspondence: amtanok@mail.ecc.u-tokyo.ac.jp
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in any medium, provided the original work is pgeneration of new enzymes exhibiting high activity, en-
hanced stability, and altered-coenzyme specificity, and
would also enable elucidation of the detailed reaction
mechanisms and substrate-binding specificities.
One of the chiral alcohols, (R)-3-quinuclidinol, is a
useful compound applicable to the synthesis of various
pharmaceuticals, such as talsaclidine and revatropate
(Rzeszotarski et al. 1988; Bietti et al. 1990; Cross and
Stobie 1993; Takeuchi et al. 1996; Alabaster 1997; Ward
et al. 1998; Leusch et al. 2000; Ishihara et al. 2004). So
far, chemical and biochemical methods have been
applied to produce (R)-3-quinuclidinol (Stembach and
Kaiser 1952; Rehavi et al. 1977; Muchmore 1993;
Bossard 1997; Brieden 1998; Matsuyama and Hamatani
1998; Sato and Enomoto 1999; Nomoto et al. 2003;
Yamamoto et al. 2003; Takenaka 2006), and most of
these methods take the approach of resolving a racemic
mixture. Recently, for the production of (R)-3-quinucli-
dinol, 3-quinuclidinone reductase (RrQR) was isolated
from Rhodotorula rubra (Uzura et al. 2009). The purified
enzyme from R. rubra is specific to NADPH as a coen-
zyme and stereospecifically produces the (R)-enantiomer
of 3-quinuclidinol from 3-quinuclidinone. Furthermore, a
coexpression system for the 3-quinuclidinone reductaseis an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Table 1 Data collection and refinement statistics of the
RrQR crystal
Data collection
X-ray source PF BL-5A
Wavelength (Å) 1.0000
Space group P41212
Unit-cell parameters (Å) a = b = 91.3, c = 265.4
Resolution (Å)a 20.0-2.20 (2.28-2.20)
Observed reflections 689047
Unique reflections 55949
Completeness (%)a 96.5 (81.0)
Rmerge (%)
a,b 9.2 (23.9)
<I>/<σ(I) > a 55.6 (11.4)
Refinement








r.m.s deviaton from ideal
Bond lengths (Å) 0.011
Bond angles (deg.) 1.43
Ramachandran plote
Most favored regions (%) 91.7
Allowed regions (%) 8.3
aData of the highest-resolution shell are shown in parentheses.
bRmerge = ∑ hkl ∑ i|Ii(hkl) − < I(hkl) > |/∑hkl ∑ i Ii(hkl), where Ii(hkl) is the i-th
intensity measurement of reflection hkl, including symmetry-related reflections,
and < I(hkl) > is its average.
cRfactor = ∑ hkl|Fobs(hkl) − Fcalc(hkl)|/∑hkl|Fobs(hkl)|.
dRfree = the cross-validation Rfactor for 5% of reflections that were not used
in refinement.
eRamachandran plot assessment using PROCHECK (Laskowski et al. 1993).
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was developed for the large-scale production of (R)-3-qui-
nuclidinol. The system using the enzyme is superior to
former kinetic resolution methods in that it has a higher
molar yield, requires no substrate modification, and so on
(Uzura et al. 2009).
Based on the amino acid similarity, RrQR belongs to
the short-chain dehydrogenase/reductase family. Though
the proteins in this family have low sequence identities,
they share a similar α/β Rossmann-fold core. In contrast
to the fold similarity, oxidoreductases, which make up
the majority of the family, exhibit various substrate spec-
ificities (Oppermann et al. 2003), indicating that the
mechanisms to accommodate structurally different sub-
strates are diverse. The molecular identification and
characterization of the enzymes of this family, which
have diverse activities capable of producing useful
molecules, would be helpful for the utilization of these
enzymes. To elucidate the detailed molecular mechan-
ism underlying the stereospecific reduction of the
3-quinuclidinone, we determined the crystal structure of
RrQR in complex with NADPH. Modeling and mutation
analyses of RrQR indicated a novel mechanism under-
lying the stereospecific reaction led by a characteristic
interaction, explaining how optically pure (R)-3-quinu-
clidinol is synthesized from 3-quinuclidinone.
Materials and methods
Crystallization and structure determination of RrQR
RrQR was expressed, purified, and crystallized as de-
scribed previously (Takeshita et al. 2009). Briefly, the
crystals were grown at 278 K using the sitting-drop
vapor-diffusion method with a reservoir solution con-
taining 100 mM CHES (pH 10.0), 30% PEG8000, and 3%
sucrose. The X-ray diffraction data set was collected
at 95 K at Beamline BL-5A of the Photon Factory,
KEK (Tsukuba, Japan). The data were processed using
HKL2000 (Otwinowski and Minor 1997). The crystals
belonged to space group P41212 with unit-cell parame-
ters of a = b = 91.3 Å and c = 265.4 Å. The data-
collection statistics of the RrQR crystal are summarized
in Table 1 and Additional file 1: Table S1. The reason for
the lower completeness in the highest resolution shell is
the limitation of the camera size at the beamline. The
reflection data to 2.2 Å resolution were used for the
structural analysis because the values of Rmerge, redun-
dancy and completeness in the highest resolution shell
are valuable for the refinement. The asymmetric unit
contained four molecules of RrQR and the RrQR struc-
ture was solved by molecular replacement using Phaser
(McCoy et al. 2007) with Thermotoga maritima TM0441
(PDB ID 1vl8) as a search model. The model was refined
using REFMAC5 (Murshudov et al. 1997) and CNS
(Brünger et al. 1998). The model was manually rebuiltusing XtalView (McRee 1999). The refined structure was
assessed using PROCHECK (Laskowski et al. 1993). The
figures were prepared with PyMOL (DeLano 2002). En-
ergy minimization of the substrate-binding model was
performed with GROMACS-4.6.3 (Hess et al. 2008) ac-
cording to online tutorials (http://www.gromacs.org/).
3-Quinuclidinone reductase assay of wild-type and
mutant RrQR enzymes
The reaction mixture comprised, in 2 ml, 500 mM
3-quinuclidinone · HCl, 566 mM glucose, 1.2 mg/ml
NAD+ or NADP+, 0.4 mg/ml glucose dehydrogenase
(Amano Enzymes, Nagoya, Japan), 200 mM potassium
phosphate buffer (pH 7.0), and an appropriate amount
of purified enzyme. After 20 h of incubation at 30°C,
the reaction was terminated by addition of an equal
volume of saturated Na2CO3, and then the formed
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of chloroform. The optical purity of 3-quinuclidinol was
determined by gas-liquid chromatography analysis, as
described previously (Uzura et al., 2009).
Mutations were introduced into the plasmid pET28a
containing the RrQR gene. The mutant proteins were
purified using a Ni-NTA column (Qiagen). The activities
of the wild-type and mutant RrQR enzymes were ana-
lyzed as follows. The standard assay mixture was com-
prised of 2.5 ml, 125 mM 3-quinuclidinone-HCl, 350
μM NADPH, and 200 mM potassium phosphate buffer
(pH 7.0), and the appropriate amount of the purified
enzyme. After 2 min of incubation without the enzyme
at 37°C, the reaction was started by adding the enzyme,
and then the decrease in absorbance at 340 nm due to
NADPH oxidation was determined. One unit of RrQR
activity was defined as the amount catalyzing the oxida-
tion of 1 μmol NADPH per min.
Accession number
Coordinates and structure factors have been deposited
in the Protein Data Bank with accession number 4O0L.
Results
Overall structure
The crystal structure of RrQR was determined at 2.2-Å
resolution and refined to a crystallographic R-factor of
0.192 and Rfree of 0.230 (Table 1 and Additional file 1:
Table S1). The asymmetric unit of the crystal contains
four protomers of RrQR. The final model includes resi-
dues 7‒272 for each protomer. There is no electron
density for N-terminus residues 1‒6 in any of the four
protomers, indicating that the region is flexible. The four
protomers in the asymmetric unit are very similar to one
another, with root-mean-square (r.m.s.) deviations of
0.20‒0.24 Å. A clear electron density for NADPH is ob-
served in each protomer, and the structures of the four
NADPH molecules in the asymmetric unit exhibit simi-
lar conformations.
The crystal structure of RrQR shows a tightly associ-
ated homotetramer (Figure 1a). The tetrameric structure
is consistent with the results of a previous gel-filtration
chromatographic analysis (Uzura et al. 2009). Like other
SDR family proteins, the RrQR protomer can be divided
into two domains: the core and small lobe structures
(Figure 1b and c). The core structure exhibits the α/β
Rossmann fold, with seven α-helices, two 310-helices and a
central parallel β-sheet consisting of seven strands. The
small lobe is away from the core, which lies between βF
and αG (residues 212-238) and contains one helix αFG. A
deep cleft exists between the core and the small lobe, and
reaches to about the middle of the molecule. The NADPH
cofactor is located at the bottom of the cleft. A remarkably
extended structure is found in the N-terminal region,consisting of residues 7‒19. There is a hydrophobic stack-
ing of P10 with Y229 on αFG of the neighboring protomer,
which would contribute to the quaternary structural sta-
bility (Additional file 1: Figure S1).
The search for structurally homologous proteins was
performed with the Dali server, and revealed several
similar proteins: β-ketoacyl acyl carrier protein reductase
(r.m.s. deviation of 1.2 Å for 229 Cα atoms (Fisher et al.
2000; PDB ID: 1edo)), trihydroxynaphthalene reductase
(r.m.s. deviation of 1.2 Å for 219 Cα atoms (Liao et al.
2001; PDB ID: 1g0n)), and mannitol 2-dehydrogenase
(r.m.s. deviation of 1.3 Å for 234 Cα atoms (Hörer et al.
2001; PDB ID: 1h5q)). Structural comparison showed
that their core structures are almost superimposable,
whereas remarkable structural diversities exist around
the cleft (Figure 1c). The cleft is formed by the small
lobe and a loop on the side opposite the lobe; this loop
lies between βE and αF (residues 171-178). In the small
lobe (S-lobe), RrQR has one helix αFG, whereas the
other enzymes each have two helices. Upon the loop,
the mannitol 2-dehydrogenase has a small antiparallel
β-sheet, and the other enzymes have different structures.
Thus, we named the loop the variable loop (V-loop)
(Figure 1c). The deep cleft is located above the B-face of
the nicotinamide ring, and it has been described as the
substrate-binding site in SDR family proteins. Therefore,
the diverse structures around the cleft could enable the
family proteins to accommodate various substrates.
NADPH-binding mode of RrQR
The bound NADPH is in an extended conformation, and
the nicotinamide and adenine rings are about 10.5 Å apart
(Figure 2). Both ribose rings are in the C2′-endo conform-
ation. The adenine ring is in the anti conformation, and
the nicotinamide ring is in the syn conformation. The con-
formation and the space above the nicotinamide ring allow
the 4-pro-S hydride transfer from the B-side of the nico-
tinamide ring. The enzyme interacts with the NADPH
through hydrogen bonds (Additional file 1: Figure S2).
Side chains of the residues R60, S61, E86, Y181, K185, and
T215 form hydrogen bonds with the NADPH molecule,
and a side chain of N113 forms a hydrogen bond with a
water molecule that is hydrogen-bonded to the NADPH
(Figure 2 and Additional file 1: Figure S2). Among these
residues, R60 and S61 form hydrogen bonds with the
2′-phosphate group of the NADPH; these bonds are in-
volved in the discrimination of NADPH from NADH. The
main chains of the other residues, G35, G37, G39, G41,
L58, A62, V87, T165, P210, and G211, also form hydrogen
bonds with the NADPH molecule.
Structure of the active site
The active site of SDR enzymes is composed of a triad
of catalytically important residues: serine, tyrosine, and
Figure 1 Overall structure of RrQR. a Overall view of RrQR. The protomers are shown in blue, red, orange, and green; NADPH molecules are
yellow (left). Side view of RrQR (right). b Stereoview of the structure of the RrQR protomer, presented in light blue. The NADPH molecule is
shown as a yellow stick model. c Stereoview of the protomer structure of RrQR, and superimposition with similar structures. RrQR, mannitol
2-dehydrogenase (PDB ID: 1h5q), and trihydroxynaphthalene reductase (PDB ID: 1g0n) are shown in blue, red, and green, respectively. The NADPH
molecule of RrQR is shown as a yellow stick model. The α-helices, αA-αG, and the β-strands, βA-βG, are labeled. The αFG between αF and αG is
also labeled. The small lobe and variable loop are encircled by dotted lines. The deep cleft is shown by a gray arrow.
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Figure 2 The NADPH-binding site of RrQR. a The NADPH molecule is represented by a stick model, and the NADPH omit FO-FC map
contoured at 3.0 σ is shown in light blue. There is no cutoff of the radius of the atoms for the display of the electron density. b Side chains of
the amino acid residues forming hydrogen bond(s) with the NADPH molecule are represented by a stick model, and the hydrogen bonds are
shown by dotted lines. Residues G37 through G39 are also shown by a stick model.
Takeshita et al. AMB Express 2014, 4:6 Page 5 of 10
http://www.amb-express.com/content/4/1/6lysine (Jörnvall et al. 1995). More recently, an asparagine
residue or a histidine residue at the corresponding pos-
ition was added to the catalytic triad (Filling et al. 2002;
Kubota et al. 2011), since a water molecule bound to the
main-chain carbonyl group of the asparagine or histidine
is assumed to participate in the reductive reaction. The
configuration of these catalytic tetrad residues is well
superimposed on that of RrQR (Figure 3a), and thus the
catalytic reaction would be achieved through the same
proton relay (Filling et al. 2002).
To identify the catalytic site where the carbonyl group
of 3-quinuclidinone is converted to the hydroxyl group,
we performed a mutation analysis of RrQR. In this
reductase, residues N138, S166, Y181, and K185 corres-
pond to the catalytic tetrad. Mutations of these residues,
S166A, Y181A, Y181F, and K185A, resulted in a complete
loss of activity (Table 2). The results reveal the catalytic
residues of RrQR, providing a basis for the reaction-based
model as described below.Substrate-binding site and 3-quinuclidinone-binding
model
A small space is found above the B-face of the nicotina-
mide ring, and is assumed to be the substrate-binding
site. This small pocket, with a diameter of 7 Å and a
depth of 8 Å, is formed by S166, I167, S168, N173,
Q178, Y181, and F212 (Figure 3b). None of these resi-
dues is charged, and the most notable characteristic of
the pocket is a hydrophobic wall composed of I167 and
F212, located at about the bottom of the pocket.To obtain further insights into the mechanism under-
lying the RrQR reaction, we built a substrate-binding
model that ensures a stereospecific reaction (Figure 4).
Structural analyses of TR-II, a member of the SDR
family, revealed that the catalytic reaction is achieved
through a slight rotational movement of the substrate
molecule (Yamashita et al. 1999; Yamashita et al. 2003).
The chemical reaction catalyzed by the enzymes TR-II
and RrQR is the same, and involves the reduction of
a carbonyl group to a hydroxyl group. Superimposition
of their structures shows that the configurations of
the catalytic residues (S166, Y181, and K185) and the
nicotinamide ring of NADPH are essentially identical
(Figure 3a). This structural similarity leads to the ra-
tional substrate-binding model of RrQR based on the
complex structure of the TR-II-substrate complex.
The ketone group of the substrates has a trigonal pla-
nar configuration, with C-C-O and C-C-C bond angles
of about 120˚. Therefore, the superimposition of the ke-
tone group (C-CO-C) of 3-quinuclidinone to that of tro-
pinone can be limited to two patterns, which are related
by a 180° rotation about the carbonyl C-O bond axis
(Figure 4a and b). The reaction is achieved through the
proton transfer to the carbonyl group of a substrate
from the catalytic residue tyrosine, and through the nu-
cleophilic attack of the hydride of NADPH on the car-
bonyl carbon of the substrate. Thereby, the hydroxyl
group of the product relocates to the side opposite that
of the nicotinamide ring. The geometry presented in
Figure 4a agrees with the catalytic reaction of RrQR,
producing (R)-3-quinuclidinol from 3-quinuclidinone.
Figure 3 The active site of RrQR. a Stereo view of the active site of RrQR and its superimposition with those of TR-II and 3β/17β-hydroxysteroid
dehydrogenase. The catalytic residues, serine, asparagine, tyrosine, and lysine, are shown by a stick model. RrQR, TR-II, and 3β/17β-hydroxysteroid
dehydrogenase are shown in light blue, pink, and pale yellow, respectively. The residues of RrQR are labeled. b Stereo view of the substrate-binding site
of RrQR. A water molecule in the active site is shown as a sphere, and hydrogen bonds are shown by dotted lines. The hydrophobic wall is comprised
of I167 and F212.
Table 2 Quinuclidinone reductase activities of the wild-type and mutant RrQR enzymes






WT 100 440 31.2 15.1




Substrate-binding site I167A ND
I167V 24.5 308 5.56 2.69
S168A 115.7 168 19.9 9.64
N173A 97.8 100 11.6 5.62




aThe analyses were performed in the presence of 125 mM 3-quinuclidinone.
bThe analyses were performed in the presence of 350 μM NADPH.
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Figure 4 Stereospecific binding for the asymmetric reduction of 3-quinuclidinone by RrQR. A 3-quinuclidinone in the active site of RrQR is
shown by a stick model and in cyan. a The catalytic model of 3-quinuclidinone-RrQR ensures the product (R)-3-quinuclidinol. The hydrophobic
wall comprised of I167 and F212 is adjacent to the hydrophobic side of the substrate, which stabilizes the substrate binding. The tertiary amine
group of the substrate is exposed to solvent. b The noncatalytic model of 3-quinuclidinone-RrQR leads to the product (S)-3-quinuclidinol. The
hydrophobic wall is adjacent to the amine group of the substrate, resulting in an unstable state. A hydrophobic surface of the substrate is
exposed to solvent. c The refined structure of RrQR by an energy minimization (red) is superimposed on the structure of the catalytic model
shown in Figure 4a (blue). d Schematic diagram of the catalytic mechanism of RrQR. The hydride transfer from NADPH to the carbonyl carbon
of 3-quinuclidinone is depicted by an arrow. The hydrophobic wall comprised of I167 and F212 is adjacent to the hydrophobic surface of the
substrate. The hydrogen bonds in the active site are shown by dotted lines. The hydroxyl group of the product is shown in red.
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the production of another stereoisomer, (S)-3-quinuclidi-
nol, which does not agree with the catalytic reaction of
RrQR. The enzyme RrQR produces only (R)-3-quinucli-
dinol. Thus we describe the geometry in Figure 4a as a
catalytic model and that in Figure 4b as a noncatalytic
model.
We then evaluated the surroundings of the active site
for the two models. The molecule 3-quinuclidinone con-
tains a tertiary amine group, which has basic and hydro-
philic properties due to a lone electron pair. In the
catalytic model, the amine group is exposed to solvent,
while on the opposite side, hydrophobic hydrocarbons of
3-quinuclidionone are buried in the small pocket and
adjacent to the hydrophobic wall composed of I167 and
F212, resulting in a stable state. On the other hand, in
the noncatalytic model, the amine group is located adja-
cent to a hydrophobic wall composed of I167 and F212,
and the hydrocarbons of 3-quinuclidinone are exposed
to the solvent, thereby resulting in an unstable state.
The differences between the two models can explain
how the RrQR enzyme produces (R)-3-quinuclidinol
prior to (S)-3-quinuclidinol from 3-quinuclidinone.
Critical residues in the substrate-binding site
The purified RrQR enzyme catalyzed the production of
(R)-quinuclidinol from 3-quinuclidinone, with an en-
antiomeric excess of >99.9% (Uzura et al. 2009). The res-
idues interacting with the substrate were predicted by
the program Ligplot (Laskowski and Swindells 2011,
Additional file 1: Figure S3), and Table 2 summarizes the
results of the mutation analysis of the substrate-binding
site. The analysis revealed that alanine mutations at
hydrophobic residues I167 and F212 significantly affect
the activity. The F212A and F212L mutants completely
lost their catalytic activity, indicating the importance of
the bulky hydrophobic property of phenylalanine. The
accessible surface areas of phenylalanine and leucine are
30.9 Å2 and 26.9 Å2, respectively. Therefore, the bulky
hydrophobic surface generated from the additional hy-
drocarbons plays a significant role in the activity. Simi-
larly, the I167A mutant lost the activity, and the I167V
mutant showed a significant decrease in the activity, to
24.5% of the wild type. With respect to the catalyticmodel presented in Figure 4a, the hydrocarbons of I167
and F212 would have direct hydrophobic interactions with
the substrate, because the distances between the substrate
and the side chains of I167 or F212 are within 4 Å.
In contrast to the mutations at the hydrophobic resi-
dues I167 and F212, the mutations at polar amino acid
residues S168, N173 and Q178 did not exhibit signifi-
cantly reduced activity (Table 2). In these mutations, the
Km values are decreased and the kcat values are de-
creased, meaning that the affinities of the mutants are
increased but the rates of the catalysis are decreased.
The higher affinities of S168A, N173A and Q178A may
be due to the increase of hydrophobicity favorable for
the substrate binding. The reductions of the kcat value of
these mutants suggest that the hydrogen network in-
cluding catalytic residue S166 may be favorable for the
reaction (Figure 4).
We subsequently refined the structure of the substrate-
binding model by means of energy minimization, indicat-
ing that slight movements of residues I167, N173 and
F212 enable the enzyme to adapt to 3-quinuclidinone
(Figure 4c). Therefore, the active site of the enzyme has a
preference for the substrate without large structural
rearrangements.
The residues forming the substrate-binding pocket are
located in the small lobe (residue F212) and on or near
the variable loop (residues I167, S168, N173, and Q178).
The two structural elements, the small lobe and the
V-loop, are characteristic structural regions of the RrQR
enzyme. Therefore, the stereospecific catalytic activity of
RrQR would be achieved by this novel substrate-binding
mechanism (Figure 4d).
Discussion
The structure of RrQR is the first structure of quinucli-
dinone reductase shown to catalyze the stereo-specific
reduction of 3-quinuclidinone. The RrQR enzyme pro-
duces (R)-3-quinuclidinol with more than 99.9% enantio-
meric excess (Uzura et al. 2009). The angles of the hydride
transfer reaction (C—H—C) have been suggested to be
rigidly restricted (Wu and Houk 1987a; Wu and Houk
1987b). However, the structural model indicates that
RrQR recognizes the substrate within a narrow area
(Figure 4). In agreement with this, the Km value for
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the RrQR enzyme would bind loosely to the substrate, but
the substrate-binding site is sufficient to accommodate
3-quinuclidinone in one direction to produce the R-form
of 3-quinuclidinol.
The substrate orientation is restricted by the circum-
stances of the catalytic site of RrQR. The substrate-
binding pocket of RrQR is largely formed by the hydro-
phobic wall. The surface of the 3-quinuclidinone is
divided into two parts, a hydrophilic face and hydropho-
bic face. Thus, the asymmetric reduction of 3-quinucli-
dinone is achieved by the ability of RrQR to discriminate
the hydrophobic surface from the hydrophilic surface of
3-quinuclidinone. The hydrophobic residues of I167 and
F212 function not only in the stereospecific substrate-
binding but also in the substrate accommodation leading
to the catalytic reaction (Table 2), and therefore we could
not analyze the effect of the mutagenesis on the stereo-
selectivity. Several compounds, including 4-chloro-3-oxo-
butanoate and ketopantoyl lactone, are catalyzed by RrQR,
but the optical purities of the products are reduced (Uzura
et al. 2009). Therefore, the size and the chemical property
of the catalytic pocket of RrQR is suitable for the binding
of 3-quinuclidinone in the specific orientation.
Structural and mutation analyses of TR enzymes have
indicated that the enzymes utilize electrostatic interac-
tions between an amine group of the substrate and
the carboxyl group of a Glu residue to determine
the substrate-binding orientations (Nakajima et al. 1998;
Nakajima et al. 1999). Similarly, levodione reductase also
utilizes the electrostatic interaction between a positively
charged surface of the substrate and a Glu residue to
bind the substrate in the specific orientation (Sogabe
et al. 2003). In contrast, the RrQR enzyme retains the
stereospecific activity exhibited by the hydrophobic wall.
Therefore, RrQR possesses a novel mechanism for the
stereospecific reaction led by a characteristic inter-
action, in which the hydrophobicity of I167 and F212
plays a crucial role in the stereospecific reduction of
3-quinuclidinone.
In conclusion, we have described the structural ana-
lysis of an enzyme that catalyzes the stereospecific
reduction of 3-quinuclidinone to (R)-3-quinuclidinol.
The three-dimensional substrate-binding model and the
mutation analysis indicate that the specific substrate-
binding would be achieved through the interactions be-
tween hydrophobic residues and a hydrophobic substrate
surface. The hydrophobic interactions would be crucial
for the asymmetric reduction of 3-quinuclidinone. The
reason for the low affinity for the substrate is that the
compound 3-quinuclidinone is not the natural substrate
for the enzyme. Therefore, it may be possible that tuning
of the enzyme by genetic strategies and/or optimization
of the reaction condition will yield an effective systemfor the expression of its maximum activity. The struc-
tural insights uncovered by this study will provide valu-
able information for investigations of enzymes that
catalyze small cyclic molecules in specific orientations.
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